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Background: The role of yogurt consumption in the development of metabolic syndrome (MetS) is not fully
understood and the available epidemiologic evidence is scarce. The aim of our study was to assess the association
between total, whole-fat, or low-fat yogurt consumption and the risk of developing MetS.
Methods: Yogurt consumption was assessed at baseline through a 136-item validated FFQ. MetS was defined
following the harmonized definition for MetS according to the AHA and the IDF criteria. Logistic regression models
were used.
Results: During the first 6-y of follow-up of the SUN cohort, 306 incident cases of MetS were identified. Frequent
consumption [≥875 g/week (≥7 servings/week) versus ≤ 250 g/week (2 servings/week)] of total, whole-fat and
low-fat yogurt consumption showed non-significant inverse associations with MetS [OR = 0.84 (95% CI: 0.60-1.18);
0.98 (95% CI: 0.68-1.41); and 0.63 (95% CI: 0.39-1.02) respectively]. Only one component of the MetS, central adiposity,
was inversely associated with total and whole-fat yogurt consumption [OR = 0.85 (95% CI: 0.74-0.98) and 0.85 (95% CI:
0.73-0.99) respectively]. In the joint assessment of exposure to total yogurt consumption and fruit consumption,
those in the highest category of total yogurt consumption, and having a high fruit consumption (above the
median ≥264.5 g/day) exhibited a significantly lower risk of developing MetS [OR = 0.61 (95% CI: 0.38-0.99)]
compared with those in the lowest category of total yogurt consumption and had fruit consumption below the
study median.
Conclusion: No significant association between yogurt consumption and MetS was apparent. Only one component
out of the 5 MetS criteria, central adiposity, was inversely associated with high yogurt consumption. The combination
of high consumption of both yogurt and fruit was inversely associated with the development of MetS.
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The term metabolic syndrome (MetS) refers to a combin-
ation of metabolic abnormalities that in the mid to long-
term increase the risk of cardiovascular disease and type 2
diabetes [1]. The 5 abnormalities included in this syn-
drome are the following: low levels of high-density lipo-
protein cholesterol (HDL-C) (<40 mg/dL and <50 mg/dL* Correspondence: mamartinez@unav.es
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unless otherwise stated.for men and women respectively, or treatment with
condition-specific medication), hypertriglyceridemia (tri-
glycerides ≥150 mg/dL or condition-specific medication),
high blood pressure (systolic ≥130 and/or diastolic ≥85
mmHg or antihypertensive drug treatment in a patient
with a history of hypertension), impaired glucose metabol-
ism (fasting plasma glucose ≥100 mg/dL, specific medica-
tion, or previous diagnosis of type 2 diabetes), and central
adiposity (in Europides, waist circumference ≥94 cm
or ≥80 cm, for men and women respectively) [2]. The
prevalence of MetS among adults in 2010 in Spain
was 22.7% [3], and, according to Alberti et al. [4], thentral. This is an Open Access article distributed under the terms of the Creative
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wide, mainly due to the increasing prevalence of obesity
and sedentary lifestyles. Therefore, nowadays MetS might
be considered an important threat to public health.
Many risk and protective factors are associated with
MetS. Some of the studied factors that might be involved
in this syndrome are related to diet composition, includ-
ing the consumption of dairy products. However, investi-
gations in this field have yielded contradictory results
[5-7]. In this context, there are some studies that have
reported an association between MetS and dairy prod-
ucts as a whole [7-9], and some that described the inde-
pendent effect of various dairy products (especially milk,
yogurt and cheese) [6,10]. Concerning results on yogurt
consumption, the conclusions obtained are all in the
same direction suggesting a significant inverse associa-
tion between yogurt consumption and the development
of MetS [7,11]. However, other studies have reported
non-significant associations [6,10]. Importantly, none of
the studies that explored the association between MetS
and yogurt have studied the potential different effects
for whole-fat and low-fat yogurt consumption. In this
context, Martinez-Gonzalez et al. recently studied the ef-
fects of whole fat and low fat yogurt consumption on
weight gain and the risk of overweight/obesity, finding
differences between the two types of yogurts [12].
A review of epidemiologic evidence relating dietary
patterns and MetS concluded that no individual dietary
component can be considered as fully responsible for
the development of MetS, and it might be possible that
the interaction between many components of the diet
may be able to protect against the development of the
MetS [13]. It has been suggested that different dietary
patterns might be associated with the development of
metabolic syndrome [14,15]. Regarding fruit and yogurt
consumption, it has been found to have a protective ef-
fect against the risk of overweight/obesity [12]. There-
fore, in order to expand the knowledge about nutritional
determinants of the MetS, we used data from 8,063
university graduates enrolled in the Seguimiento Uni-
versidad de Navarra (SUN) project, with the aim to
assess the association between total, whole-fat and
low-fat yogurt consumption and the incidence of MetS,
and secondly, to evaluate this same association taking
into account the influence of other healthy dietary
habits (such as fruit consumption and adherence to a
Mediterranean dietary pattern), among young adults
from a Mediterranean cohort.
Methods
Study population
The SUN project is a prospective, multipurpose, and dy-
namic cohort study conducted in Spain, which was ori-
ginally designed to establish associations between dietand the occurrence of several diseases and chronic con-
ditions including overweight and obesity [16]. Using
biennial mailed questionnaires participants have been
continually followed-up. Participants’ recruitment started
in December 1999, and it is permanently open. All partici-
pants are university graduates, with ages ranging from 20
to 90 years.
For the present study, we included a subsample of the
cohort with a minimum follow-up period of 6 years,
therefore only those participants who were recruited be-
fore September 2006 could be included (n = 15,909). To
avoid reverse causality bias, we excluded 4,084 partici-
pants who met at least one MetS criterion at baseline.
As recommended in nutritional epidemiology, we also
excluded 1,187 participants who reported values for total
energy intake at baseline out of predefined limits (less
than 800 kcal/d in men and 500 kcal/d in women or
more than 4,000 kcal/d in men and 3,500 kcal/d in
women). Further exclusions were 578 participants with-
out any follow-up who were considered lost to follow-
up (retention rate = 95%), and 1,997 participants who
did not provide the relevant information about diagnos-
tic criteria for the MetS at the 6th -year follow-up.
After these exclusions a total of 8,063 participants were
available for the final analysis. The retention rate of the
study was above 95%. A comparison analysis between
baseline characteristics of the participants who were in-
cluded in the study, and those participants who did not
have any information at Q_6, did not find meaningful
differences between them (data not shown).
The study was approved by the Human Research Ethical
Committee of the University of Navarra. Voluntary com-
pletion of the first self-administrated questionnaire was
considered to imply informed consent.
Dietary assessment
A semi-quantitative food frequency questionnaire (FFQ)
was included in the baseline questionnaire. The FFQ
was repeatedly validated in Spain [17-19] and includes
136 food items. Nutrient composition of specified portion
sizes was multiplied by the frequency of consumption in
order to calculate each nutrient score. Frequencies of con-
sumption were measured in 9 categories (ranging from
never/almost never, to >6 servings/day) for each food
item, in order to assess habitual dietary intakes over the
previous year. We defined a Mediterranean dietary pattern
“a priori” using the score proposed by Trichopoulou et al.
[20]. The traditional Mediterranean dietary pattern is cha-
racterized by abundant consumption of olive oil (the ma-
jor source of fat), plant foods (vegetables, fruits, cereals,
and nuts), fresh fruit as daily dessert, low-to moderate
intake of dairy products (cheese and yogurt), fish and
poultry, low intake of red meat, and regular moderate
intake of wine generally consumed during meals. For
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was appraised combining 8 out of 9 of items of the ori-
ginal score (fruits and nuts; vegetables; fish; legumes;
cereals; meat and meat products; alcohol; and the ratio
monounsaturated fatty acids/saturated fatty acids). Since
yogurt consumption is our exposure of interest, we ex-
cluded consumption of dairy products from the score.
Therefore, the score ranged from 0 to 8 points. Food com-
position tables valid for Spain were used to update the nu-
trient databank [21].
Yogurt consumption assessment
Frequency of whole-fat and low-fat yogurt consumption
in the previous year was reported by each participant in
the baseline FFQ. Frequency of total yogurt consump-
tion was estimated using the sum of these two food items
(whole-fat and low-fat yogurt consumption). The sample
was divided into three categories according to their total,
whole-fat and low-fat yogurt consumption: 0–250 g/week
(0–2 servings/week), >250 to <875 g/week, (>2 to <7 serv-
ings/week) and ≥875 g/week (≥7 servings/week); (125 g
was considered as one serving size).
Assessment of non-dietary variables
Other questions (46 items for men and 54 for women)
were also included in the baseline questionnaire asses-
sing the participants’ lifestyle, and socio-demographic
variables (sex, age, marital status, and employment), health
related habits (smoking status, physical activity during
leisure time), medical history (prevalence of chronic dis-
eases such as cancer, diabetes and cardiovascular disease),
as well as anthropometric data (weight and height) previ-
ously validated in the cohort [22]. We calculated body
mass index (BMI) as self-reported weight in kilograms
divided by the square of the self-reported height in me-
ters. Physical activity was ascertained through a baseline
17-item questionnaire Physical activity was previously
validated in a subsample of the cohort, with weekly
MET-hours shown to adequately correlate with object-
ively measured energy expenditure [Spearman ρ = 0.51;
95% confidence interval (CI): 0.232, 0.707] [23].
Outcome assessment
We defined MetS according to the American Heart
Association (AHA) and the International Diabetes Fe-
deration (IDF) criteria as outlined in the harmonized de-
finition for MetS [4]. According to this harmonized
definition, the MetS diagnosis requires the presence of
at least 3 of the 5 criteria: central adiposity (in our study
waist circumference: ≥94 cm in males and ≥80 cm in
females), hypertriglyceridemia (≥150 mg/dL or condition-
specific medication), low levels of high-density lipopro-
tein cholesterol (<40 mg/dL for men and < 50 mg/dL
for women), elevated blood pressure (systolic ≥ 130 and/ordiastolic ≥ 85 mmHg or antihypertensive drug treatment
in a patient with a history of hypertension), and impaired
glucose metabolism (fasting glucose ≥ 100 mg/dL or drug
treatment of elevated glucose). For a sensitivity analysis
we used a higher cut-off point for central adiposity (waist
circumference: ≥102 cm in males and ≥88 cm in females)
as proposed by the WHO for Caucasian populations [4].
Self-reported information about each specific MetS
criterion was collected in the Q_6 (6th year follow-up
questionnaire). With the Q_6 questionnaire, a measuring
tape and an explanation of how to measure their own
waist were sent to each participant. Diagnosis of MetS
itself, the same as each MetS criterion was previously
validated in a subsample of the cohort [24,25]. The val-
idation study for MetS diagnosis found agreement be-
tween self-reported MetS diagnosis and MetS diagnosis
from participant medical records to be 91.2% for con-
firmed MetS (95% CI: 80.7-97.1%) and 92.2% for non-
confirmed MetS (95% CI: 85.1-96.4%) [24].
Incident cases of MetS were defined as all participants
who did not have any MetS criterion at baseline, and re-
ported 3 or more criteria of MetS in the 6th year follow-
up questionnaire.
Statistical analyses
Three categories according to their baseline yogurt con-
sumption were used to classify the participants included
in the study: 0–250 g/week (0–2 servings/week), >250
to <875 g/week (>2 to <7 servings/week), and ≥875 g/
week (≥7 servings/week). The group with the lowest
frequency of consumption (0–250 g/week) was consid-
ered as the reference category.
Logistic regression models were fitted to assess the re-
lationship between total, whole-fat or low-fat yogurt
consumption at baseline and the risk of developing inci-
dent MetS during the first 6 years of follow-up. The spe-
cific relationship between each of the 5 components of
the MetS and total, whole-fat and low-fat yogurt con-
sumption were also assessed. Odds Ratios (OR) and their
95% CI were calculated. Tests for linear trend across
increasing categories of yogurt consumption were con-
ducted by assigning the median consumption within
each category and treating this variable as a continuous
variable.
The interaction between adherence to Mediterranean
diet [low (0–4 pts)/high (5–8 pts)], and fruit consumption
[low (under the median: <264.5 g/d)/high (above the me-
dian: ≥264.5 g/d)] and total yogurt consumption were
tested using likelihood ratio tests comparing the fully ad-
justed model and the same model with the interaction
product-term (2 degrees of freedom).
Additional analyses were conducted to test the associ-
ation of the joint exposure to total yogurt consumption
and fruit consumption with the risk of MetS, therefore
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to total yogurt consumption (low, medium and high
consumption) and fruit consumption (under the me-
dian and at the median or higher) considering as the
reference category those who had low yogurt consump-
tion (<250 g/week) and low fruit consumption (under
the median).
We fitted a first model without any adjustment (crude),
a second model adjusted for age and sex, and a third
multivariable-adjusted model after additional adjustment
for the following potential confounders: baseline weight
(kg), total energy intake (kcal/d), alcohol (g/d), soft drinkTable 1 Baseline characteristics of participants according to t
Consumption of total yo
0-250 g/wk
(0–2 serv/wk)
N 2,689
Age (y) 38.4 (11.2)
20-40 y (n 5429) 29.1
41-60 y (n 2492) 41.3
≥61 (n 142) 58.5
Men (%) 39.1
BMI (kg/m2) 22.9 (2.8)
Physical activity (METs-h/week) 19.0 (21.8)
Sitting time (h/d) 5.3 (2.0)
Tv watching (h/d) 1.6 (1.2)
Smoking status (%)
Current smokers 27.4
Former smokers 28.6
Total energy intake (kcal/d) 2,256 (630)
Macronutrients (% energy)
Carbohydrate intake 43.1 (7.8)
Protein intake 17.5 (3.5)
Fat intake: 37.2 (6.9)
SFA 12.8 (3.3)
MUFA 16.3 (4.0)
PUFA 5.5 (1.7)
Alcohol intake (g/d) 6.9 (10.0)
Soft drinks (ml/d) 45.0 (93.8)
Red meat (g/d) 79.4 (48.6)
French fries (g/d) 28.2 (31.9)
Fast food (g/d) 20.1 (18.8)
Adherence to the Mediterranean diet
(0[minimum] to 8[maximum] score)
4.1 (1.7)
Between-meals snacking (%) 31.7
Following special diets (%) 6.1
Values are expressed as means (SD), unless otherwise stated. BMI, Body mass ind
PUFA, polyunsaturated fatty acid.
The SUN cohort, 1999–2013.consumption (ml/d), red meat consumption (g/d), con-
sumption of French fries (g/d), consumption of fast food
(g/d), Mediterranean dietary pattern adherence (3 catego-
ries: low, medium, and high adherence), physical activity
(METs-hours/week), sitting hours (hr/d), sedentary behav-
ior (hr/d), smoking status (non-smoker, smoker, former
smoker), snacking between meals (yes/no), and following
a special diet (yes/no). Snacking between meals was de-
fined as those participants who responded affirmatively to
the question “Do you eat between main meals (snacking)?”
We did not consider if it was healthy or unhealthy snack-
ing. The percentage of participants who reported snackingheir frequency of total yogurt consumption
gurt grams per week (servings/week)
>250 to <875 g/wk
(>2 to <7 serv/wk)
≥875 g/wk
(≥7 serv/wk)
p value
3,089 2,285
35.0 (9.7) 35.8 (10.1) <0.001
41.8 29.2 <0.001
31.7 27.0
20.4 21.1
33.8 29.0 <0.001
22.7 (2.7) 22.5 (2.7) <0.001
20.6 (21.6) 23.5 (24.5) <0.001
5.4 (2.0) 5.2 (2.1) 0.059
1.6 (1.2) 1.6 (1.2) 0.191
<0.001
22.9 17.4
24.9 26.8
2,379 (591) 2,482 (580) <0.001
43.2 (6.8) 44.8 (7.0) <0.001
17.9 (3.0) 18.3 (3.2) <0.001
37.2 (6.1) 35.5 (6.4) <0.001
12.9 (2.9) 12.0 (3.1) <0.001
15.9 (3.5) 14.9 (3.5) <0.001
5.3 (1.5) 4.9 (1.5) <0.001
5.8 (7.9) 4.9 (7.1) <0.001
42.5 (66.3) 38.1 (76.9) 0.008
81.6 (44.4) 72.9 (44.6) <0.001
28.0 (29.1) 23.7 (28.1) <0.001
22.9 (21.1) 19.4 (18.6) <0.001
4.0 (1.8) 4.1 (1.8) <0.001
35.1 32.9 0.022
5.4 7.0 0.047
ex; SFA, saturated fatty acid; MUFA, Monounsaturated fatty acid;
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pant followed a special diet, if she/he answered yes to the
question “Do you follow any special diet”. If they had an-
swered yes, they were asked which kind of special diet
they followed (such as hypocaloric diet, vegetarian diet,
low-fat diet, low sodium diet, high protein diet, among
others). We used this variable dichotomously. The per-
centage of participants following a special diet was 6.1%.
For the selection of the potential confounders in the
multivariate model, and as its currently recommended
[26], we took into account the previously published sci-
entific literature including our own results based on the
cohort about risk factors for hypertension, overweight/
obesity, type 2 diabetes, avoiding exclusively the statistical
approach, the stepwise procedures, or the changes in the
point estimates after adjusting for potential confounders.
All p values presented are two-tailed; p < 0.05 was con-
sidered statistically significant. Analyses were performed
using STATA/SE version 12.0 (StataCorp, College Station,
TX, USA).
Results
The main characteristics of participants according to
their frequency of yogurt consumption are presented in
Table 1. The mean age of the participants was 36.4 y
(SD: 11.6) and the mean BMI was 22.7 kg/m2 (SD: 2.7).Table 2 Odds Ratio (OR) and 95% confidence intervals (CI) of
whole-fat, and low-fat yogurt consumption in 8,063 participa
0-250 g/week
(0–2 servings/week)
>250 to <8
(>2 to <7 s
Total yogurt
n 2,689 3,089
Incident cases 125 117
Crude 1.00 Ref. 0.81 (0.62-1.
Age and sex 1.00 Ref. 1.22 (0.93-1.
Multivariable* 1.00 Ref. 1.22 (0.92-1.
Whole fat yogurt
n 4,160 2,421
Incident cases 182 81
Crude 1.00 Ref. 0.76 (0.58-0.
Age and sex 1.00 Ref. 1.07 (0.81-1.
Multivariable* 1.00 Ref. 1.16 (0.87-1.
Low fat yogurt
n 5,990 1,242
Incident cases 233 52
Crude 1.00 Ref. 1.08 (0.79-1.
Age and sex 1.00 Ref. 1.34 (0.97-1.
Multivariable* 1.00 Ref. 1.15 (0.83-1.
*Adjusted for: age, sex, baseline weight, total energy intake, alcohol intake, soft drin
sedentary behavior, hours sitting, smoking status, snacking between meals, followinOn average participants in the highest category of total
yogurt consumption had the lowest BMI, were more
physically active, less likely to be current smokers, spent
less hours sitting, and had the highest total energy in-
take, carbohydrate and protein intake and the lowest fat
intake.
The association between the frequency of yogurt con-
sumption and the risk of incident MetS was assessed in
8,063 participants initially free of MetS. During the first
6 years of follow up we observed 306 incident cases of
MetS. As displayed in Table 2, a higher frequency of
total, whole-fat or low-fat yogurt consumption was not
significantly associated with a lower risk of developing
MetS. Participants consuming total, whole-fat and low-
fat ≥875 g/week did not exhibit significantly lower risk
of developing MetS compared with those who con-
sumed from 0 to 250 g/week. However, we observed
non-significant inverse associations [OR = 0.84 (95%
CI: 0.60-1.18); 0.98 (95% CI: 0.68-1.41); and 0.63 (95%
CI: 0.39-1.02)] respectively for total, whole-fat and low-
fat yogurt consumption, after adjusting for potential
confounders (Table 2).
The risk of developing each component of MetS ac-
cording to the total, whole-fat and low-fat yogurt con-
sumption is shown in Figure 1. This figure shows the
ORs for each component of the MetS separately forincident MetS according to baseline frequency of total,
nts of the SUN Project (1999–2013)
75 g/week
ervings/week)
≥875 g/week
(≥7 servings/week)
P for trend
2,285
64
04) 0.59 (0.43-0.80) 0.001
60) 0.85 (0.61-1.17) 0.315
62) 0.84 (0.60-1.18) 0.319
1,482
43
99) 0.65 (0.47-0.92) 0.006
42) 0.87 (0.61-1.23) 0.544
55) 0.98 (0.68-1.41) 0.885
831
21
47) 0.64 (0.41-1.01) 0.125
84) 0.74 (0.47-1.18) 0.647
61) 0.63 (0.39-1.02) 0.169
ks, red meat, French fries, fast food, Mediterranean diet, physical activity,
g special diet.
Figure 1 Multiple adjusted Odds Ratio (OR)* and 95% CI of
each MetS criteria for ≥ 875 g/week (≥7 servings/week) of
yogurt consumption [compared with ≤250 g/week (≤2
servings/week)]. The SUN Project 1999–2013. *Adjusted for: age,
sex, baseline weight, total energy intake, alcohol intake, soft drinks,
red meat, French fries, fast food, Mediterranean diet, physical activity,
sedentary behavior, hours sitting, smoking status, snacking between
meals, following special diet.
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the highest category of consumption (≥875 g/week) ver-
sus the lowest category (≤250 g/week). From the 5 com-
ponents of MetS, we observed that those participants
who consumed ≥875 g/week of total and whole-fat yogurt
compared with those who consumed ≤ 250 g/week had a
lower risk of developing central adiposity [OR = 0.85 (95%
CI: 0.74-0.98) and 0.85 (95% CI: 0.73-0.99) respectively,
after adjusting for potential confounders. The results for
the rest of the components suggested a non-significant
trend for a lower risk (except for blood pressure).
As a sensitivity analysis we changed the cut-off point
for central adiposity (waist circumference: ≥102 cm in
males and ≥88 cm in females) as proposed by the WHO
for Caucasian populations. The ORs for total, whole-
fat and low-fat yogurt consumption (≥875 g/week ver-
sus ≤250 g/week) were 0.74 (95% CI: 0.48-1.14); 0.76
(95% CI: 0.46-1.25); and 0.83 (95% CI: 0.47-1.45), respect-
ively (data not shown).
No interaction between Mediterranean diet adherence
(low/high) and total, yogurt consumption was observed
(p for interaction = 0.270). The interaction between fruit
consumption (below/above median) and total yogurt
consumption approached the threshold for statistical sig-
nificance (p for interaction = 0.070). In any case, the lowest
ORs in Table 3 were observed in the groups of partici-
pants with both a higher adherence to the Mediterranean
diet and higher consumption of total yogurt [OR = 0.77(95% CI: 0.46-1.30) p for trend = 0.323] and in participants
with both above-the-median fruit consumption and high
yogurt consumption [OR = 0.69 (95% CI: 0.43-1.10) p for
trend = 0.104] (Table 3).
When we simultaneously analyzed total yogurt con-
sumption (3 categories) and fruit consumption (2 cat-
egories), 6 new categories were created. The category of
lower yogurt consumption (≤250 g/week) and low fruit
consumption (under the median < 264.5 g/d) was con-
sidered as the reference group. We observed a signifi-
cantly lower risk of developing MetS in the group where
a higher yogurt consumption (≥875 g/week) was ac-
companied by a high fruit consumption (above the me-
dian ≥264.5 g/d) OR = 0.61 (95% CI: 0.38-0.99) (Table 4).
Discussion
The present study investigated the association between
yogurt consumption (total, whole-fat and low-fat) and
the risk of MetS in a relatively young Mediterranean
population. The results showed that yogurt consumption
itself was not significantly associated with the risk of de-
veloping MetS. A higher consumption of total and whole-
fat yogurt was found to be associated with a reduced risk
of central adiposity after adjusting for potential con-
founders. Interestingly, we found an inverse association
for the combined exposure to both high yogurt consump-
tion and high fruit consumption with the risk of MetS.
This association was not confounded by other lifestyle
factors or nutritional patterns because it remained sta-
tistically significant after multiple adjustments for these
potential confounding factors.
Our findings are consistent with some previous cross-
sectional studies indicating an inverse but non-significant
association between yogurt consumption and MetS [6,10].
Another cross-sectional study, had found a meaningful in-
verse association [11]. The lack of significance in our
study might be explained by the low incidence that we
found in our cohort 3.8% in comparison with the 25.8 %
of MetS prevalence that other studies have reported
[11]. Furthermore, the findings of cross-sectional studies
should be interpreted with caution because this design, by
nature, is more prone to reverse causality bias.
There are some reports in the literature relating
the consumption of dairy –and in some cases yogurt
consumption– with some specific isolated criteria of
the MetS (central adiposity, low high-density lipopro-
tein cholesterol, elevated blood pressure, and impaired
glucose metabolism or type 2 diabetes). In this context,
when we analyzed separately each component of the
MetS, we found a significant inverse association be-
tween total and whole-fat yogurt consumption and the
incidence of central adiposity. This association might
be explained by the theory that calcium intake can re-
duce lipogenesis and increase lipolysis. Therefore, an
Table 3 Odds Ratio (OR) and 95% confidence intervals (CI) of incident Metabolic Syndrome according to the baseline
total yogurt consumption stratified by adherence to the Mediterranean diet and fruits consumption
0-250 g/week
(0–2 servings/week)
>250 to <875 g/week
(>2 to <7 servings/week)
≥875 g/week
(≥7 servings/week)
P for trend P for interaction
Stratified by adherence to the Mediterranean diet (MeDiet)
0.270
Low MeDiet Adherence (0 to 4)
N 1851 2079 1362
Incident cases 75 78 35
Crude 1.00 Ref. 0.92 (0.67-1.28) 0.62 (0.42-0.94) 0.024
Age and sex 1.00 Ref. 1.43 (1.01-2.02) 0.94 (0.61-1.43) 0.820
Multivariable 1.00 Ref. 1.37 (0.96-1.96) 0.86 (0.55-1.35) 0.538
High MeDiet Adherence (5 to 8)
N 838 1010 923
Incident cases 50 39 29
Crude 1.00 Ref. 0.63 (0.41-0.97) 0.51 (0.32-0.82) 0.006
Age and sex 1.00 Ref. 0.94 (0.60-1.47) 0.75 (0.46-1.22) 0.250
Multivariable* 1.00 Ref. 0.96 (0.60-1.54) 0.77 (0.46-1.30) 0.323
Stratified by fruit consumption
0.070
Low fruit consumption
N 1482 1636 914
Incident cases 60 64 30
Crude 1.00 Ref. 0.96 (0.67-1.38) 0.80 (0.51-1.26) 0.343
Age and sex 1.00 Ref. 1.38 (0.94-2.01) 1.12 (0.71-1.78) 0.569
Multivariable* 1.00 Ref. 1.39 (0.94-2.05) 1.06 (0.65-1.73) 0.750
High fruit consumption
N 1207 1453 1371
Incident cases 65 53 34
Crude 1.00 Ref. 0.67 (0.46-0.96) 0.45 (0.29-0.68) <0.001
Age and sex 1.00 Ref. 1.08 (0.73-1.61) 0.71 (0.46-1.11) 0.123
Multivariable* 1.00 Ref. 1.05 (0.70-1.59) 0.69 (0.43-1.10) 0.104
*Adjusted for: age, sex, baseline weight, total energy intake, alcohol intake, soft drinks, red meat, French fries, fast food, Mediterranean diet (only when stratified
by fruit consumption), physical activity, sedentary behavior, hours sitting, smoking status, snacking between meals, following special diet.
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lead to an increase in fat oxidation [27,28]. A relationship
between microbiota and obesity has been reported by
some studies. It is thought that this effect could be medi-
ated by actions such as inflammatory/anti-inflammatory
effects of microbiota. Lactobacillus and Bifidobacterium
that come from dairy products, including yogurt, are sug-
gested to positively modulate the gut microbiota and may
help to prevent or treat some diseases [29].
Our longitudinal results are novel, but they are in some
ways consistent with 2 previous long-term prospective
studies that did not specifically assess MetS. The first
study was conducted by Mozaffarian et al. [30] using data
from three large American cohorts. They found that
yogurt consumption was inversely associated with weightgain during the follow-up [−0.82 lb/serving (95% CI: −0.99
to −0.67 lb/serving) in a 4-y period]. Additionally, Wang
et al. [31], as a part of the in the Framingham Heart Study
Offspring, found that yogurt consumption was also associ-
ated with less average weight gain (p for trend = 0.03).
The second component of MetS that was analyzed was
impaired glucose metabolism or type 2 diabetes. We did
not find any significant association between yogurt con-
sumption at baseline with the likelihood of meeting this
criterion after 6 of follow-up. One recent meta-analysis
[32] found that consumption of 50 g/d of yogurt was as-
sociated with a lower risk of developing this component,
finding a pooled RR of 0.91 (95% CI: 0.82–1.00). The
average age of participants in the studies included in that
meta-analysis was in general over 50 years, whereas the
Table 4 Odds Ratio (OR)* and 95% CI of incident MetS
according to baseline frequency of total yogurt
consumption and fruit consumption in 8,063 participants
of the SUN Project (1999–2013)
Yogurt consumption Fruit consumption
Low (<264.5 g/d) High (≥264.5 g/d)
Low (≤250 g/wk, ≤2
servings/wk)
N/incident cases 60/1482 65/1207
Multivariable 1.00 (Ref.) 0.89 (0.59-1.34)
Moderate (>250
to < 875 g/wk, >2
to < 7 servings/wk)
N 64/1636 53/1453
Multivariable 1.40 (0.95-2.05) 0.92 (0.61-1.42)
High (≥875 g/wk, ≥7
servings/wk)
N 30/914 34/1371
Multivariable 1.07 (0.66-1.72) 0.61 (0.38-0.99)
*Adjusted for: age, sex, baseline weight, total energy intake, alcohol intake,
soft drinks, red meat, French fries, fast food, Mediterranean diet, physical
activity, sedentary behavior, hours sitting, smoking status, snacking between
meals, following special diet.
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This difference may explain the apparent null associ-
ation between yogurt consumption and glucose abnor-
malities in our cohort, and the discrepancies between
our study and the meta-analysis.
For the two lipid components of the metabolic syn-
drome (high triglycerides and low HDL-C) we did not
find any significant association with frequent yogurt con-
sumption, even though, in all cases our non-significant es-
timates were in the direction of an inverse association.
Our results are in the same direction as those found by
Kim et al. [10], who reported an inverse but not significant
association between yogurt consumption and these 2
components of the MetS.
Finally, when we analyzed high blood pressure, we did
not find any association with frequent yogurt consump-
tion. These results might seem contradictory to the results
previously found in our SUN cohort by Alonso et al. [33].
In that study we reported that a low-fat “dairy” consump-
tion, but not whole-fat dairy consumption, was associated
with a lower risk of incident hypertension. In that study,
skim and partially skim milk were the major contributors
to low-fat dairy consumption and accounted for 92% of
the total low-fat dairy consumption. By contrast, in the
current assessment we only evaluated yogurt consumption
and not milk. However, we conducted a secondary ana-
lysis including all low-fat dairy products (including par-
tially skim milk, skim milk, skim yogurt, cottage cheese
and white fresh cheese) and observed an inverse andsignificant association between low-fat dairy consump-
tion and the incidence of hypertension [OR = 0.81 (95%
CI: 0.67-0.98)] for the highest quintile of consumption
compared with the lowest, after adjusting for potential
confounders (data not shown).
When we analyzed the association between total yogurt
consumption and the risk of MetS, stratifying participants
according to the adherence to the Mediterranean dietary
pattern or according to fruit consumption there was a
suggestion of a lower risk of developing MetS among par-
ticipants with a higher adherence to the Mediterranean
dietary pattern, and also among those with high fruit con-
sumption. These results are in accordance with the results
reported by Joung et al. [15], who found that a “fruit,
salad, cereal and fish” pattern were negatively but not sta-
tistically associated with the risk of MetS.
When we simultaneously analyzed total yogurt con-
sumption and fruit consumption, we found that the ca-
tegory of a combined exposure to both higher yogurt
consumption and high fruit consumption was signifi-
cantly associated with a lower risk of developing MetS.
This is in agreement with the conclusion of a review
study conducted by Baxter et al. [13] that suggested that
it is more likely that the interactions between many
components of the diet or the overall quality of a dietary
pattern offer protection against MetS than each of the
isolated food components.
The self-reported outcome might be considered as a
major limitation of our study. However, the MetS diag-
nosis itself [24] and each one of the 5 self-reported MetS
components [25] were previously validated in our cohort,
finding intraclass correlation coefficients between 0.5 to
0.9 (p < 0.001) depending on the criteria, against a gold
standard of direct assessments by an experienced phys-
ician. Self-reported weight and BMI were also validated in
a subsample of the cohort, finding a mean relative error
for weight and BMI of 1.45% and 2.64% respectively [22].
Although we have adjusted for potential confounding
factors, since this is an observational study, we cannot
completely rule out the possible existence of residual
confounding.
The present study has several strengths, including the
prospective design, which limits the possibility of reverse
causality bias, the use of previously validated methods
published in reputed journals [17-19,22-25], the large
sample size, and the high educational level of our partic-
ipants which allows a better understanding of the ques-
tionnaire and reduces the potential for misclassification
bias. Although, we should be cautious with respect to the
generalization of the results.
Conclusions
The findings of this study showed that high consump-
tion of yogurt at the same time with a high consumption
Sayón-Orea et al. BMC Public Health  (2015) 15:170 Page 9 of 10of fruits was inversely associated with the development
of MetS. Additionally, no association between yogurt con-
sumption with MetS was observed, and only one compo-
nent out of 5, central adiposity, was inversely associated
with high yogurt consumption in this Mediterranean
population.
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